Synthetic Cannabinoids Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029

Published on : Feb-2020 | List of Tables : 90 | List of Figures : 87 | No. of Pages : 170 | Report Code : FACT4156MR | Format :

Rapid Adoption of Therapeutic Drugs to Augment Demand of Synthetic Cannabinoids

Synthetic cannabinoids have emerged as a novel therapeutic drug for epilepsy, spasticity, inflammation etc. Synthetic cannabinoids for medical purposes have been commercialized since 2016 and are showing rapid adoption for different medical ailments. Synthetic cannabinoid market is projected to grow at an astounding CAGR of more than 16% during forecast period 2019 – 2029 showcasing a dexterous growth as per Fact.MR’s latest report. Synthetic cannabinoids to treat nausea and anxiety caused by cancer chemotherapy are projected to open new growth avenues for synthetic cannabinoids manufacturers. Moreover, synthetic cannabinoid therapies for diseases such as arthritis, acute and chronic pain will bolster demand of synthetic cannabinoids during forecast period.

Synthetic Cannabinoids Sales to Soar as Dronabinol Maintains its Lead

Dronabinol is a prominent synthetic cannabinoids which holds more than two third market share in global market. Dronabinol for medical use is being manufactured by almost all prominent market players. Moreover, Dronabinol is an emerging suitable therapeutic compound which binds to cannabinoid (CBR) receptor giveing desired results during disease treatment.

Novel Techniques Such as Biosynthesis to Increase Foothold of Market Leaders

Earlier manufacturers of synthetic cannabinoids were using naïve techniques of production with help of specialized strains of yeast. Companies such as Librede, Inc. and Hyasynth Biologicals Inc. are actively producing synthetic cannabinoids by using bioengineered yeast strains. Other manufactures of synthetic cannabinoids such as Renew Biopharma have been innovating the production process of synthetic cannabinoids with help of bioengineered microorganisms. The use of bioengineered microorganisms for synthesis of synthetic cannabinoids instead of conventional processes help enhance purity of compound.

Legalization in Potential Markets to Generate New Revenue Streams for Synthetic Cannabinoids

Cannabinoids have been legalized in many countries and this number is expected to increase in the forecast period. Synthetic cannabinoids will benefit from authorization for medical usage. Countries such as China and India are prominent drug and pharmaceutical markets where synthetic cannabinoid legalization for pharmaceutical applications may play a vital role in boosting sales of synthetic cannabinoids in countries. By region Latin America is projected to grow 6.8X during the forecast period as countries in Latin America are embracing legalization of synthetic cannabinoids in a big way. North America on the other hand will continue to maintain its hegemony in terms of market share.

synthetic cannabinoids market opportunity assessment by region

To get exhaustive regional insights on synthetic cannabinoids market, ask an analyst here

New Pipeline of Synthetic Cannabinoid Drugs Projected to Proliferate Market Growth

Manufacturers of synthetic cannabinoid drugs are running clinical trials and phase studies for different drugs which are likely to hit the market in the next two to three years. This will significantly escalate the demand for synthetic cannabinoids. Some of the companies such as CV Sciences, Inc. are focused on carrying out all phase clinical trials of the initial drug candidate (CVSI-007) in the foreseeable future. Moreover, Insys Therapeutics, Inc. has synthetic cannabinoids compounds under the development phase. The company is developing Dronabinol inhalation for agitation in Alzheimer’s disease and cancer induced anorexia. Manufacturers are thus escalating demand for synthetic cannabinoid in the near future.

Leading Players to Expand Production Capacity of Synthetic Cannabinoids

Synthetic cannabinoid market players are partnering with research associations and organizations to carry out potential research in synthetic cannabinoids. Few pharma giants are investing in startup companies to push research on synesthetic cannabinoids and expand production capacities of synthetic cannabinoids. For instance, in 2019, Noramco announced that its cannabinoids business division will become a separate company named Purisys, LLC and is expanding its production capacity of Dronabinol and cannabidiol in its production facility based in Athens, United Sates.

synthetic cannabinoids market intensity mapping

To attain a formidable edge on your competition in the synthetic cannabinoids market, request for a report sample here

Synthetic cannabinoids market is anticipated to witness a notable upsurge during the forecast period 2019 to 2029, conferring to a new Fact.MR study. The study promotes crucial trends that are presently determining the growth of synthetic cannabinoids market. This newly published and perceptive report sheds light on vital dynamics, which are likely to convert the future of synthetic cannabinoids market, in turn generating worthwhile opportunities for key companies as well as evolving players who are interested in the production of synthetic cannabinoids.

Synthetic cannabinoids market study is a detailed market intellect on key revenue progression factors, challenges, industry trends, and opportunities, which will eventually influence the growth of synthetic cannabinoids market. The report primarily conveys a summary of the synthetic cannabinoids market, considering present and upcoming cannabis industry scenarios, to reveal striking sides relating to the acceptance of synthetic cannabinoids across prominent regional markets.

A detailed assessment on few of synthetic cannabinoids manufacturers and suppliers accessible in the report allows the report readers to obtain detailed findings that have resulted from synthetic cannabinoids supply chain analysis, business execution, and value chain analysis across the regional markets incorporated in the report. A list of prominent companies functioning in synthetic cannabinoids market provided in the report enhances reliability of this ample research study.

Synthetic Cannabinoids Market: Report Summary and Scope

Study offers a comprehensive overview on diverse features that are inducing demand, revenue generation and sales in synthetic cannabinoids market across the globe.

A comprehensive estimate on synthetic cannabinoids market has also been made accessible by the experts, who have considered the market estimates on the basis of a likely scenario, an optimistic scenario, and a conservative scenario regarding sales of synthetic cannabinoids during the forecast period. Analysis and estimation of price point comparison by region and by type with the global average price has been included in this study.

Synthetic Cannabinoids Market: Segmentation

FactMR’s study has done the segmentation of synthetic cannabinoids market on the basis of type, and region.

Type

Region

Dronabinol

Nabilone

North America

Latin America

Europe

Asia Pacific

MEA

Synthetic Cannabinoids Market: Analysis on Market Size Evaluation

Predictions of synthetic cannabinoids market, encompassing current as well as forthcoming projected values estimate and analysis on region-wise demand trends and price index have been assimilated in the report.

Market estimates at the regional and global scale for synthetic cannabinoids are available in terms of “US$ Mn.” A Y-o-Y growth contrast on prominent synthetic cannabinoids market segments, along with the market attractiveness valuation computes understandings brought in the report. Metrics mentioned above are also followed based on synthetic cannabinoids applications where synthetic cannabinoids witness a steady demand.

Synthetic Cannabinoids Market: Scrutinized Assessment on Regional Segments

Weighted sections have been elaborated in the report on synthetic cannabinoids market, which delivers projection on the regional markets. These chapters brighten the regional macros (political economic, and business environment outlook), which are expected to have a significant impact on the growth of synthetic cannabinoids market during period of forecast.

Country-specific valuation on demand for synthetic cannabinoids has been offered for each regional market, along with the market scope estimate and forecast, price index, price point assessment, and impact analysis of dynamics of prominent regions and countries. For all regional markets Y-o-Y growth estimates have also been incorporated in the report.

Synthetic Cannabinoids Market: In-depth Analysis on Competitive Landscape

The report ends with a section on the competition scenario of synthetic cannabinoids market, along with the profiles of major companies contributing to the market expansion. Essential and up-to-date data as well as information correlated to the market performers, who principally engage in the production and supply of synthetic cannabinoids, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to plan preemptive steps to advance their businesses.

Company profiles have been shared with report, which exerts essentials such as product portfolio, along with an all-inclusive SWOT analysis on each player recognized along with the company policies identification and analysis. The company presence has been mapped and presented through the matrix for all the prominent players of the market functioning in synthetic cannabinoids market which offers readers with actionable intellect. This helps in thoughtfully presenting the market status, and making decisive predictions on the competition levels in synthetic cannabinoids market. Major companies operating in global synthetic cannabinoids market, include Noramco, Inc., Hyasynth Biologicals, Inc., Insys Therapeutics, Inc., CV Sciences, Inc., Ginkgo Bioworks, Inc., CannBioRx Life Sciences, CB Therapeutics, Inc., Librede, Inc. and others.

1. Global Synthetic Cannabinoids Market - Executive Summary

    1.1. Global Market Overview

    1.2. Industry Attributes

    1.3. Key Market Statistics

    1.4. Fact.MR Analysis and Recommendation

2. Global Synthetic Cannabinoids Market Data – Introduction

    2.1. Market Coverage / Taxonomy

    2.2. Market Introduction and Definition

3. Key Market Trends

    3.1. Key Trends Impacting Market

        3.1.1. Companies using Novel Compounds for Synthesis

        3.1.2. Companies Pushing for Clinical Trials

        3.1.3. Bio-tech start-ups entering the synthetic cannabinoids market

        3.1.4. Others

4. Market Background and Associated Industry Indicators

    4.1. Key Cannabis Producing Countries Overview

        4.1.1. Cannabis Production Capacity, By Key Country

        4.1.2. Quality of Cannabis

    4.2. Global CBD Infused Food & Beverages Market Overview Normal

        4.2.1. CBD infused Beverages Market Value (US$ Mn)

        4.2.2. CBD infused Edibles Market Value (US$ Mn)

    4.3. Government Policies & their Impact

        4.3.1. Impact of Government policies on Cannabis Cultivation

        4.3.2. Impact of Government Policies on Synthetic Cannabinoid Market

    4.4. Per Capita Spending on Cannabis Product, By Regions

    4.5. Recent Investment Announced in Synthetic Cannabinoid Market

    4.6. Market Dynamics

        4.6.1. Drivers

        4.6.2. Restraints and Market Risks

        4.6.3. Opportunity Analysis in Synthetic Cannabinoid Market & Impact Analysis

    4.7. Forecast Factors – Relevance & Impact

5. Global Synthetic Cannabinoids Market Demand Analysis 2018 and Forecast, 2019-2029

    5.1. Current and Future Market Volume (Kgs) Projections, 2019-2029

    5.2. Y-o-Y Growth Trend Analysis

6. Global Synthetic Cannabinoids Market - Pricing Analysis

    6.1. Regional Pricing Analysis By Type

    6.2. Pricing Break-up by Region

    6.3. Global Average Pricing Analysis Benchmark

    6.4. Factors Influencing Pricing

7. Global Synthetic Cannabinoids Market Demand (in Value or Size in US$ Mn) Analysis 2018 and Forecast, 2019-2029

    7.1. Current and Future Market Value (US$ Mn) Projections, 2019-2029

        7.1.1. Y-o-Y Growth Trend Analysis

        7.1.2. Absolute $ Opportunity Analysis

8. Global Synthetic Cannabinoids Market Demand (US$ Mn) Analysis 2018 and Forecast, 2019-2029

    8.1. Current and Future Market Value (US$ Mn) Projections, 2019-2029

        8.1.1. Y-o-Y Growth Trend Analysis

        8.1.2. Absolute $ Opportunity Analysis

        8.1.3. Key Takeaways

9. Global Synthetic Cannabinoids Market Demand Analysis 2018 and Forecast, 2019-2029

    9.1. Current and Future Market Volume (Tons) Projections, 2019-2029

    9.2. Y-o-Y Growth Trend Analysis

10. Global Synthetic Cannabinoids Market Analysis 2018 and Forecast 2019-2029, By Type

    10.1. Introduction / Key Findings

    10.2. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2019 – 2029

        10.2.1. Dronabinol

        10.2.2. Nabilone

        10.2.3. Market Attractiveness Analysis By Type

11. Global Synthetic Cannabinoids Market Analysis 2018 and Forecast 2019-2029, by Region

    11.1. Introduction / Key Findings

    11.2. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

        11.2.1. North America

        11.2.2. Latin America

        11.2.3. Europe

        11.2.4. Asia Pacific

        11.2.5. Middle East and Africa (MEA)

    11.3. Market Attractiveness Analysis By Region

12. North America Synthetic Cannabinoids Market Analysis 2018 and Forecast 2019-2029

    12.1. Introduction

    12.2. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

            12.2.1.1. By Country

            12.2.1.2. U.S.

            12.2.1.3. Canada

        12.2.2. By Type

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type

    12.4. Latin America Synthetic Cannabinoids Market Analysis 2018 and Forecast 2019-2029

    12.5. Introduction

    12.6. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

        12.6.1. By Country

            12.6.1.1. Uruguay

            12.6.1.2. Argentina

            12.6.1.3. Brazil

            12.6.1.4. Mexico

            12.6.1.5. Rest of Latin America

        12.6.2. By Type

    12.7. Market Attractiveness Analysis

        12.7.1. By Country

        12.7.2. By Type

13. Europe Synthetic Cannabinoids Market Analysis 2018 and Forecast 2019-2029

    13.1. Introduction

    13.2. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

        13.2.1.  By Country

            13.2.1.1. Germany

            13.2.1.2. Italy

            13.2.1.3. France

            13.2.1.4. UK

            13.2.1.5. Benelux

            13.2.1.6. Rest of Europe

        13.2.2. By Type

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Type

14. Asia Pacific Synthetic Cannabinoids Market Analysis 2018 and Forecast 2019-2029

    14.1. Introduction

    14.2. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        14.2.1. By Country

            14.2.1.1. Thailand

            14.2.1.2. South Korea

            14.2.1.3. Australia

            14.2.1.4. New Zealand

        14.2.2. By Type

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Type

15. Middle East and Africa Synthetic Cannabinoids Market Analysis 2018 and Forecast 2019-2029

    15.1. Introduction

    15.2. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

        15.2.1. By Country

            15.2.1.1. South Africa

            15.2.1.2. Israel

            15.2.1.3. Rest of Middle East and Africa

        15.2.2. By Type

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Type

16. Market Structure Analysis

    16.1. Global Synthetic Cannabinoids Market Competition - a Dashboard View

    16.2. Global Synthetic Cannabinoids Market Structure

    16.3. Market Share Analysis of Top Players

17. Company Profiles

    17.1. Hyasynth Biologicals, Inc.

        17.1.1. Company Overview

        17.1.2. Product Portfolio

        17.1.3. Key Developments

        17.1.4. Key Strategies

    17.2. Noramco, Inc.

        17.2.1. Company Overview

        17.2.2. Product Portfolio

        17.2.3. Key Developments

        17.2.4. Key Strategies

    17.3. CB Therapeutics, Inc.

        17.3.1. Company Overview

        17.3.2. Product Portfolio

        17.3.3. Key Developments

        17.3.4. Key Strategies

    17.4. Insys Therapeutics, Inc.

        17.4.1. Company Overview

        17.4.2. Product Portfolio

        17.4.3. Key Developments

        17.4.4. Key Strategies

    17.5. CV Sciences, Inc.

        17.5.1. Company Overview

        17.5.2. Product Portfolio

        17.5.3. Key Developments

        17.5.4. Key Strategies

    17.6. Ginkgo Bioworks, Inc.

        17.6.1. Company Overview

        17.6.2. Product Portfolio

        17.6.3. Key Developments

        17.6.4. Key Strategies

    17.7. CannBioRx Life Sciences

        17.7.1. Company Overview

        17.7.2. Product Portfolio

        17.7.3. Key Developments

        17.7.4. Key Strategies

    17.8. LIBREDE, INC.

        17.8.1. Company Overview

        17.8.2. Product Portfolio

18. Research Methodology

19. Assumptions and Acronyms

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Synthetic Cannabinoids Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029